During the past decade, Szpital Specjalistyczny w Prabutach Sp. z o.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpital Specjalistyczny w Prabutach Sp. z o.o." #1 sponsor was "Bioven Europe" with 1 trials, followed by "Celgene" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Genmab" with 1 trials sponsored and "Helsinn Healthcare SA" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny w Prabutach Sp. z o.o." #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny w Prabutach Sp. z o.o." are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Non Small Cell Lung Cancer Metastatic" (1 trials), "Non-Small-Cell Lung Adenocarcinoma" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny w Prabutach Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Szpital Specjalistyczny w Prabutach Sp. z o.o." are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Topotecan" (2 trials), "Amrubicin" (1 trials), "Aprepitant" (1 trials) and "DS-1062a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Specjalistyczny w Prabutach Sp. z o.o." are 7 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Specjalistyczny w Prabutach Sp. z o.o.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Szpital Specjalistyczny w Prabutach Sp. z o.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Specjalistyczny w Prabutach Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".